Barhemsys

Active Ingredient(s): Amisulpride
FDA Approved: * February 26, 2020
Pharm Company: * ACACIA PHARMA LTD
Category: Nausea & Vomiting

Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; and at higher doses by mouth to treat schizophrenia and acute psychotic episodes. It is sold under the brand names Barhemsys[8] (as an antiemetic) and Solian, Socian, Deniban and others (as an antipsychotic).[5] It is also used to treat dysthymia.[9] It is usually classed with the atypical antipsycho... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Barhemsys 2.5 mg/ml Intravenous Injection, Solution
NDC: 71390-125
Labeler:
Acacia Pharma Ltd